🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Phase I Combination Study of CYC065 and Venetoclax for Relapsed or Refrac...
Status
Completed
Location
MD Anderson Cancer Center
Start Date
2019-08-02
Trial ID
NCT04017546
Treatments Being Tested
This is a Phase 1 dose-escalation study of PRT1419, a myeloid cell leukemia...
Status
Terminated
Location
Mid Florida Hematology and Oncology Center
Start Date
2022-03-22
Trial ID
NCT05107856
Treatments Being Tested
The goal of this clinical trial is to investigate the short-term changes in...
Status
Active Not Recruiting
Location
Essilor R&D Centre Singapore
Start Date
2025-11-11
Trial ID
NCT07253064
A Phase I Combination Study of CYC065 and Venetoclax for Relapsed or Refrac...
Status
Completed
Location
Investigational Site
Start Date
2019-01-25
Trial ID
NCT03739554
Treatments Being Tested
The purpose of this two-stage Phase 2 study is to assess the clinical respo...
Status
Terminated
Location
Honor Health Research Institute
Start Date
2016-03-14
Trial ID
NCT02520011
Treatments Being Tested
This research study is studying whether a new experimental cancer study dru...
Status
Withdrawn
Location
Dana Farber Cancer Institute
Start Date
2016-02
Trial ID
NCT02656849
Treatments Being Tested
The CL1-64315-001 study is a phase I, international, multicentre, open-labe...
Status
Completed
Location
Patient Care Location: Smilow Cancer Hospital at Yale
Start Date
2017-03-15
Trial ID
NCT02979366
Treatments Being Tested
The purpose of this study is to assess the safety, tolerability and clinica...
Status
Completed
Location
University of Texas MD Anderson Cancer Center Department of Leukemia, Division of Cancer Medicine
Start Date
2021-02-17
Trial ID
NCT04629443
Treatments Being Tested
The purpose of this study is to determine the safety profile, tolerability ...
Status
Completed
Location
Smilow Cancer Hospital at Yale
Start Date
2018-11-28
Trial ID
NCT03672695
Treatments Being Tested
Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hod...
Status
Not Yet Recruiting
Location
Department of Hematology, The First Affiliated Hospital, School of Medicine, Zhejiang University
Start Date
2025-09-08
Trial ID
NCT07159906
Treatments Being Tested